Yahoo Web Search

Search results

1. • 

     Sanofi (SNY) Terminates Pompe Disease Deal as FTC Objects

     Zacks via Yahoo Finance· 6 months ago

     Sanofi (SNY) decides to end the licensing deal with Maze Therapeutics for MZE001, a phase II ready...

2. • 

     Maze lands new partner for Pompe drug, after Sanofi pact came apart

     BioPharma Dive via Yahoo Finance· 4 weeks ago

     Dive Brief: Biotechnology startup Maze Therapeutics has licensed a Pompe disease drug to Shionogi,...

3. • 

     With help from Duke doctors, a rare genetic disease is treated in the womb for the first time

     Raleigh News and Observer via AOL· 2 years ago

     For the first time, doctors started treating a fetus with Pompe disease, a rare and often fatal...

4. • 

     Sanofi (SNY) Wins Nod for Nexviadyme & Xenpozyme in Europe

     Zacks via Yahoo Finance· 2 years ago

     Sanofi's (SNY) Nexviadyme is approved for the treatment of both late-onset Pompe disease and...

5. • 

     Amicus (FOLD) Gets Pompe Disease Treatment Approval in Europe

     Zacks via Yahoo Finance· 1 year ago

     Amicus FOLD announced that the European Commission approved cipaglucosidase alfa, commercialized...

6. • 

     Amicus (FOLD) Gets FDA Approval for Pompe Disease Drug

     Zacks via Yahoo Finance· 8 months ago

     Amicus Therapeutics FOLD announced that the FDA approved Pombiliti (cipaglucosidase alfa) + Opfolda...

7. • 

     Shionogi secures licence for Maze’s Pompe disease treatment

     Pharmaceutical Technology via Yahoo Finance· 4 weeks ago

     Shionogi has concluded an exclusive global licence agreement for Maze Therapeutics’ MZE001, an oral...

8. • 

     In a first, doctors treat fatal genetic disease before birth

     Associated Press via Yahoo News· 2 years ago

     A toddler is thriving after doctors in the U.S. and Canada used a novel technique to treat her...

9. • 

     Sanofi In-Licenses Pompe Disease Therapy From Privately-Held Maze Therapeutics For $150M Upfront

     Benzinga via Yahoo Finance· 1 year ago

     Maze Therapeutics has signed an exclusive worldwide license agreement with Sanofi SA (NASDAQ: SNY)...

10. • 

      Disease screening for newborns varies by state. For some, that means diagnoses come too late.

      NBC Universal via AOL· 12 months ago

      The lists of diseases for which newborns are tested vary by state. Parents of kids with Krabbe...